184 related articles for article (PubMed ID: 38436957)
21. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
22. Failure of radioactive iodine in the treatment of hyperthyroidism.
Schneider DF; Sonderman PE; Jones MF; Ojomo KA; Chen H; Jaume JC; Elson DF; Perlman SB; Sippel RS
Ann Surg Oncol; 2014 Dec; 21(13):4174-80. PubMed ID: 25001092
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
Okamura K; Bandai S; Fujikawa M; Sato K; Kitazono T
Endocr J; 2020 Jul; 67(7):751-758. PubMed ID: 32238669
[TBL] [Abstract][Full Text] [Related]
24. Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: The utility of long-term antithyroid drugs.
Levy MJ; Reddy N; Price D; Bhake R; Bremner E; Barrowcliffe M; Kieffer V; Robinson C; Zaccardi F; Howlett TA
Clin Endocrinol (Oxf); 2022 Nov; 97(5):643-653. PubMed ID: 35274339
[TBL] [Abstract][Full Text] [Related]
25. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
26. Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis?
Iakovou I; Giannoula E; Chatzipavlidou V; Sachpekidis C
Hell J Nucl Med; 2020; 23(1):94-95. PubMed ID: 32361719
[TBL] [Abstract][Full Text] [Related]
27. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience.
Gill DS; Greening JE; Howlett TA; Levy MJ; Shenoy SD
J Pediatr Endocrinol Metab; 2019 Feb; 32(2):151-157. PubMed ID: 30685744
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
30. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
Saadat N; Azizi F; Abdi H; Amouzegar A
J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
[TBL] [Abstract][Full Text] [Related]
31. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
[TBL] [Abstract][Full Text] [Related]
32. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
33. Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
Kim MJ; Cho SW; Kim YA; Choi HS; Park YJ; Park DJ; Cho BY
Endocrinol Metab (Seoul); 2022 Jun; 37(3):524-532. PubMed ID: 35709827
[TBL] [Abstract][Full Text] [Related]
34. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
35. Management of Graves Disease: A Review.
Burch HB; Cooper DS
JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
[TBL] [Abstract][Full Text] [Related]
36. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
37. Revisiting the role of surgery in the treatment of Graves' disease.
Cohen O; Ronen O; Khafif A; Rodrigo JP; Simo R; Pace-Asciak P; Randolph G; Mikkelsen LH; Kowalski LP; Olsen KD; Sanabria A; Tufano RP; Babighian S; Shaha AR; Zafereo M; Ferlito A
Clin Endocrinol (Oxf); 2022 Jun; 96(6):747-757. PubMed ID: 34954838
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.
Jin M; Jang A; Kim CA; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
Eur Thyroid J; 2023 Apr; 12(2):. PubMed ID: 36826832
[TBL] [Abstract][Full Text] [Related]
39. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
[TBL] [Abstract][Full Text] [Related]
40. Managing toxic thyroid adenoma: a cost-effectiveness analysis.
Vidal-Trecan GM; Stahl JE; Durand-Zaleski I
Eur J Endocrinol; 2002 Mar; 146(3):283-94. PubMed ID: 11888833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
